0.5856
price down icon1.25%   -0.0074
pre-market  Vorhandelsmarkt:  .60   0.0144   +2.46%
loading

Pavmed Inc Aktie (PAVM) Neueste Nachrichten

pulisher
06:33 AM

What drives PAVmed Inc. stock pricePhenomenal capital appreciation - PrintWeekIndia

06:33 AM
pulisher
12:10 PM

What analysts say about PAVmed Inc. stockSuperior stock growth - PrintWeekIndia

12:10 PM
pulisher
Jul 24, 2025

PAVmed Inc. Stock Analysis and ForecastExplosive trading growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 22, 2025

Is PAVmed Inc. a good long term investmentDynamic profit opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 17, 2025

Why PAVmed Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - beatles.ru

Jul 17, 2025
pulisher
Jul 17, 2025

Lucid says meeting scheduled to determine Medicare coverage for cancer test - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

Lucid says AdCom meeting set to determine cancer test coverage - Seeking Alpha

Jul 16, 2025
pulisher
Jul 16, 2025

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - StreetInsider

Jul 16, 2025
pulisher
Jul 15, 2025

How PAVmed Inc. stock performs during market volatilityFree Low-Risk Investment Plans - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes PAVmed Inc. stock price move sharplyLow Volatility High Yield Stocks - Newser

Jul 15, 2025
pulisher
Jun 24, 2025

PAVmed's Veris Health Secures $2.5M at $35M Valuation to Advance Revolutionary Cancer Monitor - Stock Titan

Jun 24, 2025
pulisher
Jun 23, 2025

PAVmed’s Veris Health Completes $2.5M Offering - TipRanks

Jun 23, 2025
pulisher
Jun 18, 2025

PAVmed Holds Annual Stockholders Meeting, Approves Key Proposals - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Leading California Hospital Network Launches Revolutionary 3-Minute Cancer Detection Test from Lucid Diagnostics - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - Finansavisen

Jun 18, 2025
pulisher
Jun 07, 2025

PAVmed (NASDAQ:PAVM) Given New $19.00 Price Target at Ascendiant Capital Markets - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know - MSN

Jun 07, 2025
pulisher
Jun 06, 2025

PAVM: Ascendiant Capital Maintains Buy Rating but Lowers Price Target | PAVM Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 04, 2025

PAVmed subsidiary Veris Health partners with Ohio State University cancer center - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Pavmed's Veris Health Signs Long-Term Partnership Deal With Ohio State University Hospital - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

PAVmed Subsidiary, Veris Health, Enters into Strategic Partnersh - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

PAVM Subsidiary Veris Health Partners with OSUCCC -- James for Cancer Care Innovations | PAVM Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer CenterJames Cancer Hospital and Solove Research Institute | PAVM Sto - GuruFocus

Jun 03, 2025
pulisher
May 27, 2025

Lucid Diagnostics joins Russell 2000 and 3000 indexes - Mugglehead Magazine

May 27, 2025
pulisher
May 27, 2025

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - The Malaysian Reserve

May 27, 2025
pulisher
May 27, 2025

Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes - Investing.com

May 27, 2025
pulisher
May 27, 2025

Lucid Diagnostics to join Russell 2000 and Russell 3000 indexes By Investing.com - Investing.com UK

May 27, 2025
pulisher
May 23, 2025

Lucid Diagnostics Joins Elite Russell Indexes, Opens Door to $10.6T Investment Pool - Stock Titan

May 23, 2025
pulisher
May 16, 2025

PAVmed Inc. (NASDAQ:PAVM) Q1 2025 Earnings Call Transcript - Insider Monkey

May 16, 2025
pulisher
May 16, 2025

PAVmed Inc (PAVM) Q1 2025 Earnings Call Highlights: Strategic Expansion and Financial Fortification - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Pavmed Inc. Reports Turnaround with Strong Q1 Earnings - TipRanks

May 16, 2025
$286.58
price down icon 0.03%
medical_devices STE
$227.25
price up icon 0.79%
medical_devices PHG
$25.84
price down icon 0.04%
$86.74
price up icon 0.36%
$76.77
price down icon 0.62%
medical_devices EW
$75.80
price down icon 1.44%
Kapitalisierung:     |  Volumen (24h):